Community Health Systems (CYH) Q3 2026 earnings review
Community Health visits rise, but weak insurance mix cuts profit
Community Health Systems treated more patients at its remaining hospitals, but fewer of them had private insurance or needed complex care. Sales at hospitals owned a year ago grew 3.8%, while total revenue fell 11% after the hospital chain sold ten facilities this year. Because patients arrived with less coverage and doctor subsidies rose, cash profit dropped by a quarter to $280 million, and chief executive Kevin Hammons lowered expectations for the rest of the year.
| Sales from hospitals owned a year ago | +3.8% +2.4% in Q2 |
|---|---|
| Total revenue | $2.76B -10.7% from a year ago after hospital sales |
| Adjusted EBITDA (cash profit) | $280M -25.5% from a year ago (10.2% margin) |
| Full-year 2026 outlook | Cut lowered for a second straight quarter |
⚖️ Verdict: 🔴 Bearish
The story got worse because rising patient visits failed to bring in earnings, forcing a second straight cut to the full-year plan. Even as underlying hospital volume accelerated, cash profit missed the pace needed for the July plan by $51 million, pushing net debt up to 7.2 times trailing cash profit by our math. One bright spot: third-quarter operating cash flow more than doubled from a year ago to $155 million as customer billings stabilized.
The question now is whether the weak insurance mix is a temporary economic dip or a lasting shift from federal Medicaid and subsidy cuts. If it is temporary, growing patient visits will eventually refill operating rooms and lift profit; if it is permanent, extra patients only bring unpaid bills. The fourth-quarter surgical mix and uninsured share of revenue will tell.
🐂 Bull Case
Patient Visits Accelerated at Hospitals Owned a Year Ago
Community Health Systems operates acute-care hospitals and outpatient clinics, including ambulatory surgery centers where patients have procedures without staying overnight. Admissions at hospitals owned a year ago rose 2.2%, and adjusted admissions—which combine inpatient stays and outpatient visits into one volume measure—grew 3.6%, up from 2.9% in the second quarter.
That volume gain lifted sales from businesses owned a year ago by 3.8%, compared with 2.4% growth last quarter. By our math, underlying revenue per adjusted admission edged up 0.2% from a year ago, reversing the 0.5% decline in the second quarter even against a prior-year period that included state payment catch-ups.
What to watch: same-store surgical volumes and outpatient clinic additions on the conference call. Growing surgical procedures would show that outpatient clinic investments are bringing in privately insured patients rather than just emergency room visits.
Third-Quarter Operating Cash Flow More Than Doubled
Cash collection has been a major strain this year as insurance companies audited more claims before paying them. In the third quarter, cash generated from operating activities reached $155 million, more than double the $70 million collected a year ago and up from $87 million in the second quarter.
Patient accounts receivable—money owed by patients and insurers—stood at $2.10 billion, up just 1.2% from the end of 2025. That slower build helped free cash flow reach $68 million in the quarter by our math, though total operating cash flow for the first nine months remains negative at $55 million.
What to watch: days revenue outstanding in the quarterly filing. A drop from the second quarter's 59 days would confirm that insurance payment delays are easing.
🐻 Bear Case
Weak Payer Mix and Acuity Force Another Outlook Cut
Chief executive Kevin Hammons said that "payor mix and acuity did not develop as expected due to the challenging macro environment", which hurt third-quarter results and lowered "our expectations for the remainder of the year". Payer mix measures the share of patients with private insurance versus government plans or no coverage, while acuity measures how complex and profitable their medical treatments are.
- Adjusted EBITDA (cash profit before interest, taxes and one-offs): $280 million, down 25.5% from a year ago
- Adjusted EBITDA excluding last year's $28 million legal settlement: down 19.5% by our math
- Adjusted EBITDA margin: 10.2% of revenue, down 2.0 percentage points from 12.2% a year ago
- Net loss per share, excluding one-offs: $0.48 loss, compared with $1.27 profit a year ago
Hammons has previously described soft patient mix as a temporary disruption, but this marks the second straight quarter the hospital group has cut its full-year plan. Even though hospitals treated 3.6% more same-store visits, those visits arrived with less insurance coverage and simpler medical needs, causing quarterly cash profit to miss the pace implied by the July plan by $51 million.
What to watch: the exact updated full-year Adjusted EBITDA range from the outlook tables. A cut below $1.25 billion would show that fourth-quarter seasonal strength is not materializing.
Medical Specialist Fees Keep Pushing Operating Costs Up
Hospitals must pay outside doctor groups, such as anesthesiologists and emergency room specialists, to staff their facilities around the clock. When privately insured surgical volumes fall, the hospital chain must pay higher subsidies to meet income guarantees for those doctors. In addition, states charge hospitals fees to fund supplemental Medicaid payment programs.
Community Health Systems cited "higher medical specialist fees and supplemental reimbursement program expense" as primary reasons earnings fell in the third quarter. Those costs sit inside other operating expenses, which climbed 2.4 percentage points to 29.3% of revenue, while salaries and benefits rose 0.2 percentage points to 44.1%. Together, they pushed operating margin down 2.6 percentage points to 5.3%.
What to watch: the growth rate of medical specialist fees on the earnings call. Any rate near the second quarter's 19% increase would keep squeezing margins even if patient visits rise.
Debt Burden Stays Heavy Despite Hospital Sales
The Franklin, Tennessee-based company has been selling hospitals to pay down its borrowings. Over the first nine months of 2026, it collected $1.21 billion from selling facilities and reduced total debt by $810 million to $9.59 billion ($9.43 billion in net debt after subtracting $155 million of cash).
Because the sold hospitals took their earnings with them and remaining hospital profits shrank, the debt burden relative to earnings worsened. By our math, net debt is now 7.2 times trailing 12-month Adjusted EBITDA of $1.31 billion, up from 6.7 times reported last quarter. Meanwhile, net interest expense consumed $201 million in the third quarter, or 72% of Adjusted EBITDA.
What to watch: management's reported net leverage ratio on the call. A figure above 6.7 times confirms that selling hospitals is no longer lowering the company's debt ratio.
Risks this quarter didn't answer
Pages 16 and 17 of the earnings release, along with the quarterly filing and conference call remarks, were not included in the supplied materials, leaving four standing risks unread.
- Updated 2026 outlook tables: referenced on page 3 as appearing on pages 16 and 17, which are cut off after page 14 in the filing excerpt.
- Florida 2026 state-directed payment program: whether the plan has been submitted to federal regulators, which decided the top and bottom of the prior earnings range.
- Uninsured and self-pay revenue share: disclosed each quarter in the filing's revenue note to show if the 2025 federal health law is still increasing uncompensated care.
- Goodwill impairment test: $3.23 billion of goodwill remains on the balance sheet ahead of the annual fourth-quarter accounting review.
👓 Other Themes
Ten Hospital Sales Reshaped the Year-Over-Year Comparison
Through October 28, Community Health Systems sold nine hospitals and its 80% stake in a tenth, reducing its network from 70 hospitals a year ago to 59 today. Because reported financials include sold hospitals in prior periods until the day they close, total revenue dropped 10.7% to $2.76 billion and total admissions fell 12.3%, masking the 3.8% revenue growth at continuing hospitals.
💲 Other KPIs
Medical supplies fell to 14.8% of net operating revenues, down 0.1 percentage points from 14.9% a year ago. Over the first nine months, supplies dropped 0.5 percentage points to 14.6% of revenue. Lower surgical complexity reduced the need for expensive implants, which helped offset higher doctor subsidies.
Purchases of property and equipment were $239 million for the first nine months, which by our math means the healthcare group spent $87 million in the third quarter, up from $65 million a year ago. Nine-month spending equals 2.8% of revenue and leaves $111 million to $161 million for the fourth quarter under the prior plan.
Weighted-average diluted shares rose 0.7% from 135 million a year ago and decreased by 1 million from the second quarter. The hospital operator did not buy back stock, directing all cash from hospital sales toward paying down debt.
🔮 Guidance
Cut. Chief executive Kevin Hammons said weak payer mix and patient acuity hurt expectations for the rest of the year. While pages 16 and 17 containing the exact numbers are missing from the supplied excerpt, nine-month Adjusted EBITDA of $918 million means the company would need $382 million in the fourth quarter—up 36% from the third quarter—just to reach the bottom of its July plan.
❓ Key Questions
What are the new full-year 2026 outlook ranges?
The release states on page 3 that updated 2026 annual earnings tables appear on pages 16 and 17, which were cut off in the provided document. Investors need the new revenue, Adjusted EBITDA, and operating cash flow ranges.
Has Florida submitted its 2026 directed payment plan?
Last quarter, management said the $75 million gap between the top and bottom of its full-year earnings plan depended on federal approval of Florida's 2026 Medicaid payment program. Did a delay in Florida cause the outlook cut?
How much did medical specialist fees grow this quarter?
Other operating expenses jumped 2.4 percentage points of revenue to 29.3%, and the release blamed specialist fees. After these subsidies rose 19% in the second quarter, investors need to know if doctor guarantee costs are still accelerating.
Did inpatient surgical volumes recover in the third quarter?
Same-store inpatient surgeries fell 3.8% last quarter, hurting both revenue mix and anesthesia subsidy costs. Hammons said acuity missed expectations in the third quarter, raising the question of whether profitable surgeries declined again.